Thoracic aortic aneurysm pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 34: Line 34:
*[[ACTA2]]: This is one of the genes involved in [[familial thoracic aortic aneurysm and dissection]] ([[FTAAD]]).
*[[ACTA2]]: This is one of the genes involved in [[familial thoracic aortic aneurysm and dissection]] ([[FTAAD]]).


<br />
=== Pathogenesis ===
* The exact pathogenesis of [disease name] is not completely understood.
OR
* It is understood that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
* [Pathogen name] is usually transmitted via the [transmission route] route to the human host.
* Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
* [Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
* The progression to [disease name] usually involves the [molecular pathway].
* The pathophysiology of [disease/malignancy] depends on the histological subtype.
<br />
===Gross Pathology===
===Gross Pathology===
[http://www.peir.net Images shown below are courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology]
[http://www.peir.net Images shown below are courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology]


== Associated Conditions[edit | edit source] ==
Conditions associated with [disease name] include:
* [Condition 1]
* [Condition 2]
* [Condition 3]


<div align="left">
== Microscopic Pathology ==
On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].<div align="left">
<gallery heights="175" widths="175">
<gallery heights="175" widths="175">
Image:Aortic aneurysm 1.jpg|Dissecting Aneurysm: Gross very good example dissected channel has been opened
Image:Aortic aneurysm 1.jpg|Dissecting Aneurysm: Gross very good example dissected channel has been opened

Revision as of 17:35, 7 December 2019

Thoracic aortic aneurysm Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thoracic Aortic Aneurysm from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

General Approach to Imaging in Thoracic Aortic Aneurysm

Chest X Ray

MRI

CT

Echocardiography

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Endovascular Stent Grafting

Lifestyle Changes

Special Scenarios

Management during Pregnancy

Case Studies

Case #1

Thoracic aortic aneurysm pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thoracic aortic aneurysm pathophysiology

CDC on Thoracic aortic aneurysm pathophysiology

Thoracic aortic aneurysm pathophysiology in the news

Blogs on Thoracic aortic aneurysm pathophysiology

Directions to Hospitals Treating Thoracic aortic aneurysm pathophysiology

Risk calculators and risk factors for Thoracic aortic aneurysm pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]

Overview

An aneurysm occurs when a part or entire circumference of the vessel is pathologically dilated. A true aneurysm involves all three layers of the vessel, whereas pseudoaneurysm is characterized by disruption of the intima and media, and the dilated segment of the aorta is lined by adventitia alone.

Pathophysiology

  • The clinical manifestations of thoracic aortic aneurysms depends on hemo-dynamic factors as well as factors intrinsic to individual arterial components.
  • Cystic medial necrosis is the most common pathology associated with ascending aortic aneurysms, whereas atherosclerosis is most frequently involved in the arch and descending aorta.
  • The aortic aneurysms associated with marfan syndrome grow at a faster rate and are more prone to rupture.
  • Most thoracic aneurysms are asymptomatic. However, the enlarging aorta can compress adjacent organs and cause symptoms like chest pain, dyspnea, hoarseness of voice, cough and dysphagia. Also symptoms of congestive heart failure can occur from severe aortic regurgitation and congestion of head, neck and upper extremities from superior vena cava compression.

Elastin and Collagen

  • Increased activity of certain enzymes causes degradation of elastin and collagen in the arteries. This leads to loss of elasticity, weakens the aortic wall and causes it to dilate.
  • Moreover, the part of aorta below the origin of renal arteries has less amount of elastin compared to collagen, accounting for increased frequency of aneurysms in this area.
  • In patients with marfan's syndrome there is a defect on chromosome 15 that is associated with impaired fibrillin synthesis, which is the core protein of microfibrils. Frequently among patients with marfan's syndrome there is cystic medial degeneration.

Hemodynamic Factors

  • The aorta being a low resistance circuit, repeated trauma from a reflected wave results in dilatation.
  • Systemic hypertension accelerates the process of dilatation of aorta and contributes to the formation of aneurysms.

Genetics


Pathogenesis

  • The exact pathogenesis of [disease name] is not completely understood.

OR

  • It is understood that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
  • [Pathogen name] is usually transmitted via the [transmission route] route to the human host.
  • Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
  • [Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
  • The progression to [disease name] usually involves the [molecular pathway].
  • The pathophysiology of [disease/malignancy] depends on the histological subtype.


Gross Pathology

Images shown below are courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology

Associated Conditions[edit | edit source]

Conditions associated with [disease name] include:

  • [Condition 1]
  • [Condition 2]
  • [Condition 3]

Microscopic Pathology

On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].





















References

Template:WH Template:WS